IMMUNE NETWORK LTD (CIK: 0001097907) EDGAR, Information, Filings... CompaniesBIO.Com

IMMUNE NETWORK LTD

Mailing address
3650 WESBROOK MALL, VANCOUVER BC CANADA V6S 2L2, VANCOUVER BC, A1
Phone
6042225541
State location
A1
State of incorporation
N/A
Fiscal year end
December 31
SIC
8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Filings
N/A

IMMUNE NETWORK LTD (CIK: 0001097907) is an American company incorporated in the state of A1. Head office is located at 3650 WESBROOK MALL, VANCOUVER BRITISH COLUMBIA, CANADA V6S 2L2, A1, 00000. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. IMMUNE NETWORK LTD is a public company and trade via Over-The-Counter (OTC).

Old names:

IMMUNE NETWORK RESEARCH LTD from 1999-29-Oct to 2000-30-Jun

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by IMMUNE NETWORK LTD

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-13-000272 (34 Act) Size: KB	Jan-17-2013	000-27883 13533677
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001221508-03-000003 ( Act) Size: KB	Mar-11-2003	000-27883 03599063
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000523 ( Act) Size: KB	Sep-11-2002	000-27883 02761736
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000496 ( Act) Size: KB	Sep-05-2002	000-27883 02756903
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001085037-02-000494 ( Act) Size: KB	Sep-03-2002	005-58447 02755216
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000480 ( Act) Size: KB	Aug-22-2002	000-27883 02745903
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001085037-02-000460 ( Act) Size: KB	Aug-20-2002	005-58447 02743298
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000386 ( Act) Size: KB	Jul-30-2002	000-27883 02714368
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001085037-02-000352 ( Act) Size: KB	Jul-16-2002	000-27883 02703644
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000343 ( Act) Size: KB	Jul-09-2002	000-27883 02698249
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001085037-02-000328 ( Act) Size: KB	Jun-28-2002	000-27883 02690978
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000278 ( Act) Size: KB	May-24-2002	000-27883 02661482
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001085037-02-000175 ( Act) Size: KB	Apr-08-2002	000-27883 02604578
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001085037-02-000127 ( Act) Size: KB	Feb-27-2002	005-58447 02559297
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001085037-02-000123 ( Act) Size: KB	Feb-25-2002	005-58447 02556626
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001062993-01-500312 ( Act) Size: KB	Oct-17-2001	000-27883 1761094
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001062993-01-500174 ( Act) Size: KB	Jul-30-2001	000-27883 1692525
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001062993-01-500161 ( Act) Size: KB	Jul-16-2001	000-27883 1681814
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001062993-01-500139 ( Act) Size: KB	Jun-29-2001	000-27883 1670919
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001062993-01-500106 ( Act) Size: KB	May-30-2001	000-27883 1650094

Recent 20 filings. View all IMMUNE NETWORK LTD filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Where is IMMUNE NETWORK LTD's headquarters?

IMMUNE NETWORK LTD is located in 3650 WESBROOK MALL, VANCOUVER BRITISH COLUMBIA, CANADA V6S 2L2, A1, 00000.

What is the IMMUNE NETWORK LTD's website?

IMMUNE NETWORK LTD's website is unknown

Who invested in IMMUNE NETWORK LTD?

Updating!

How much funding has IMMUNE NETWORK LTD raised to date?

Updating!

When was the last funding round for IMMUNE NETWORK LTD?

Updating!

When was IMMUNE NETWORK LTD founded?

Updating!

IMMUNE NETWORK LTD overview
IMMUNE NETWORK LTD job
IMMUNE NETWORK LTD stock
IMMUNE NETWORK LTD ownership
IMMUNE NETWORK LTD CEO
IMMUNE NETWORK LTD documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.